Sexcellence Awards 2017: SHNS Honours Ruthie Patriquin & Cathie Penny

Sexual Health Nova Scotia (SHNS) is proud to announce the recipients of the 2017 Sexcellence Awards.

Since 2008, SHNS has given the Sexcellence Award to individuals in Nova Scotia who support and promote outstanding work in the field of sexual health education. 

This year's "Sexcellent" recipients are: 
•    Ruthie Patriquin, outgoing executive director of the Sexual Health Centre for Cumberland County (SHCCC)
•    Cathie Penny, former executive director of the Cape Breton Centre for Sexual Health (CBCSH)

Statement on Al-Rawi verdict: Clearly a drunk person cannot consent

Statements made by provincial court Judge Gregory Lenehan in his March 1 acquittal of Halifax taxi driver Bassam Al-Rawi have drawn attention to the misconceptions that still exist around sexual violence.

Sexual Health Nova Scotia is committed to working to end sexual violence in this province. This work rests on the firm belief that consent must be clearly given, it must be affirmative, and it must be ongoing.

#StormReads: 50 Books to Check Out for SRH Week

As more winter weather sweeps across the province, why not curl up indoors with a good book?

In celebration of Sexual & Reproductive Health Awareness Week 2017, we pulled together a list of our 50 Recommended Reads on everything to do with sex, gender, orientation, pleasure, politics, and safety.

It's not an exhaustive list - please let us know if you have more suggestions! - but it should be enough to keep you going through a few more snow days.

Sexual & Reproductive Health Awareness Week: Ready for some pillow talk?

Sexual & Reproductive Health Awareness Week is finally here! This year's theme for SRH Week is "pillow talk"...by which we mean open communication about sexual health.

Sexual Health Centre for Cumberland County is Hiring!

Sexual Health Centre for Cumberland County, our member-centre in Amherst, is hiring a new full-time Executive Director. See the details on our Opportunities page.

Abortion drug Mifegymiso faces additional restrictions

The campaign to reduce barriers to abortion access in Canada continues to face obstacles. A story published today in The Globe & Mail online reveals that the medical abortion drug Mifegymiso may not be covered by most provincial drug plans when it becomes available later this year.

Without drug coverage, people who wish to take Mifegymiso will have to pay anywhere from $270 to $300 out of pocket.

According to the Globe: